Ashley Adams
About Ashley Adams
Ashley Adams is the Director of Discovery Chemistry at Exscientia, where she has worked since 2022. She has extensive experience in medicinal chemistry, having held positions at AbbVie and GSK, and holds multiple degrees in chemistry from prestigious institutions.
Current Role at Exscientia
Ashley Adams serves as the Director of Discovery Chemistry at Exscientia. She has held this position since 2022, contributing to the advancement of drug discovery processes. In her role, she oversees various projects aimed at integrating artificial intelligence with medicinal chemistry to enhance the efficiency of drug development.
Previous Experience at AbbVie
Prior to her current role, Ashley Adams worked at AbbVie for a total of six years. She served as a Senior Scientist I from 2015 to 2018 and then as a Senior Scientist II from 2018 to 2021. During her tenure at AbbVie, she focused on medicinal chemistry, contributing to the development of therapeutic candidates.
Experience at GSK
Ashley Adams worked at GlaxoSmithKline (GSK) as a Team Leader in Lead Discovery Medicinal Chemistry from 2021 to 2022. In this role, she led a team focused on the discovery of new drug candidates, utilizing her extensive background in medicinal chemistry to guide research efforts.
Educational Background
Ashley Adams has a strong academic foundation in chemistry. She earned her Doctor of Philosophy (Ph.D.) in Chemistry from Stanford University, where she studied from 2009 to 2014. She also completed a Ph.D. at Princeton University in 2008-2009. Earlier, she obtained a Bachelor of Arts in Chemistry and Chemical Biology from Cornell University from 2004 to 2008.
Research Experience
In addition to her academic achievements, Ashley Adams has gained research experience through various internships and positions. She worked as a Graduate Student at Stanford University from 2009 to 2015 and as a Graduate Student at Princeton University for 11 months in 2008-2009. Earlier, she was a Summer Student at University College Dublin in 2007 and an R&D Intern at Intervet in 2005.